Journey Medical (DERM) Other Working Capital Changes (2020 - 2026)

Journey Medical has reported Other Working Capital Changes for 7 years, with the latest figure at -$25000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 96.94% year-over-year to -$25000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (down 20.18% YoY), and the FY2025 full-year result was $2500.0, down 90.5% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$25000.0, down from -$23000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $2.4 million in Q4 2022, with the low at -$830000.0 in Q1 2022.
• Historically, Other Working Capital Changes has averaged $202777.9 across 5 years, with a median of $9684.0 in 2022.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 644.34% — and 2025, when it tumbled 65460.0%.
• Journey Medical's Other Working Capital Changes stood at $2.4 million in 2022, then slumped by 85.68% to $339000.0 in 2023, then surged by 590.27% to $2.3 million in 2024, then tumbled by 100.98% to -$23000.0 in 2025, then fell by 8.7% to -$25000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$25000.0 (Q1 2026), -$23000.0 (Q4 2025), and $2500.0 (Q3 2025), per Business Quant data.